Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Personalized Photoprotection: Sunscreens, Visible Light, and Emerging Sun Protection Strategies
Description
The presentation reviewed modern photoprotection as a personalized, evidence-based strategy that goes beyond sunscreen alone to include shade, clothing, sunglasses, and emerging non-topical and biologic approaches. It emphasized that visible light can drive pigmentary changes, especially in darker skin, and that in the U.S. tinted sunscreens containing iron oxides are currently the best option for visible-light protection, though their labeling can be confusing because iron oxide is listed as an inactive ingredient. The speaker highlighted promising European filters with broader UVA and visible-light coverage, especially upcoming FDA consideration of BEMT, a photostable, broad-spectrum filter with high molecular weight and minimal absorption. The talk also covered “PINs” (topical non-filter photoprotective ingredients) such as vitamins C, B3, E, green tea polyphenols, thiamidol, N-acetylcysteine, photolyase, and melanisyl, noting that most published evidence is weak and only a small fraction is strongly supported. A key theme was personalized advice based on skin type: lighter skin generally needs higher SPF, while darker skin may benefit more from stronger UVA and visible-light protection to reduce pigmentary change, though U.S. regulatory standards make UVA ranking less informative than in Europe. The Q&A addressed visible light’s uncertain broader harms, limited evidence for harm from computer/phone blue light, the modest but useful evidence for oral polypodium leucotomos as an adjunct rather than a replacement for sunscreen, and the challenges of selecting organic versus inorganic filters. The session concluded that patients should receive balanced counseling reflecting both the known harms of sunlight and the emerging, less certain data on benefits and newer protective strategies.
View moreConclusions
- Effective photoprotection should be presented as a total package that includes shade, clothing, hats, sunglasses, sunscreens, and selected non-topical agents rather than sunscreen alone.
- For protection against visible light and long-wave UVA, tinted sunscreens containing iron oxides are especially useful in the United States, while newer European filters such as Mexoryl 400, TriAsorB, and BDBP show broader wavelength coverage.
- The evidence base for non-filtering photoprotective ingredients is generally weak, with only a small fraction of PINGs supported by strong clinical data.
- Among non-filtering agents, antioxidants, depigmenting compounds, and DNA-repair ingredients such as vitamin C, nicotinamide, thiamidol, photolyase, and related agents appear to be the most promising.
- Personalized photoprotection is warranted because optimal advice depends on skin phototype, skin color, and other individual factors rather than a one-size-fits-all approach.
- Lighter-skinned individuals generally need higher UVB protection because they are more prone to sunburn and skin cancer, whereas darker-skinned individuals may need relatively less SPF but more emphasis on UVA and visible-light protection to prevent pigmentation.
- Visible light clearly contributes to pigment darkening and erythema, but other harmful effects such as photoaging or skin cancer remain insufficiently proven.
- Current evidence suggests that blue light from common personal devices is not intense enough to cause meaningful skin pigment changes.
- Oral and topical adjuncts such as polypodium leucotomos can reduce, but not replace, conventional sun protection.
- The field is moving toward broader sunscreen options and more user-friendly regulation, with FDA expansion of approved active ingredients viewed as an important step forward.
- Jansen, R, et al. JAAD 12/13; 69:853 & 866.
- Brown A. et al., Br J Dermatol. 2025 May 19;192(6):1132.
- Krutmann J. et al., Photodermatol Photoimmunol Photomed. 2025 Nov;41(6):e70062.
- J Am Acad Dermatol 2023 Sept; 89:635.
- Photodermatol Photoimmunol Photomed 2024 April; 40:e12967.
- Personalized Photoprotection: Expert Consensus and Recommendations From a Delphi Study Among Dermatologists, PMID/PMCID/DOI listed.#10.1111/phpp.70001
- T Passeron, H W Lim, … J Ocampo Candiani, … S Schalka, et al. JEADV 2021 Jul;35:1460.